Geron Corp. (GERN) Monday released a study supporting the using stem cells in making vaccines to fight cancer and other diseases. It said the study shows cells that trigger immunity responses that...
Geron Corp. (GERN) agreed to provide stem cells to General Electric Co.'s (GE) GE Healthcare for use in tools that test drug treatments for their toxic effects on the body, particularly the heart...
Geron Corp. (GERN) and General Electric Co.'s (GE) GE Healthcare announced a global licensing deal in which the companies will team up to develop and sell drug-discovery technologies derived from...
By Val Brickates Kennedy Drug stocks followed the broader market north early Tuesday, pushed higher by news that troubled Citigroup Inc. (C) had turned a profit during the first two months of the...
By Val Brickates Kennedy News that U.S. drugmakers Merck & Co. (MRK) and Schering-Plough Corp. (SGP) plan to merge did little to stoke trading in the sector early Monday, as the benchmark...
The Food and Drug Administration's clearing the way for Geron Corp. (GERN) to conduct the first human trial of an embryonic stem cell treatment is just the beginning of a long journey for the...
AUSTIN, Texas, Jan. 16 /PRNewswire-USNewswire/ -- Start Licensing, Inc. ("Start"), a joint venture of Geron Corporation and Exeter Life Sciences supports the final risk assessment released by...
Advanced Cell Technology Announces Favorable Ruling on Human Applications of Nuclear Transfer, Issuance of Patent, and Intent to Appeal Adverse Ruling on Animal Claims WORCESTER, Mass., Feb. 24...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.